We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Medtronic (MDT) Stock Moves -1.61%: What You Should Know
Read MoreHide Full Article
Medtronic (MDT - Free Report) closed at $91.73 in the latest trading session, marking a -1.61% move from the prior day. Meanwhile, the Dow lost 0.16%, and the Nasdaq, a tech-heavy index, added 0.55%.
The medical device company's shares have seen a decrease of 2.11% over the last month, not keeping up with the Medical sector's gain of 7.99% and the S&P 500's gain of 3.83%.
The investment community will be closely monitoring the performance of Medtronic in its forthcoming earnings report. The company is scheduled to release its earnings on November 18, 2025. The company is predicted to post an EPS of $1.31, indicating a 3.97% growth compared to the equivalent quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $8.86 billion, up 5.44% from the year-ago period.
For the full year, the Zacks Consensus Estimates are projecting earnings of $5.62 per share and revenue of $35.83 billion, which would represent changes of +2.37% and +6.82%, respectively, from the prior year.
It is also important to note the recent changes to analyst estimates for Medtronic. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.01% lower. Medtronic presently features a Zacks Rank of #3 (Hold).
With respect to valuation, Medtronic is currently being traded at a Forward P/E ratio of 16.6. This valuation marks a discount compared to its industry average Forward P/E of 18.01.
Also, we should mention that MDT has a PEG ratio of 2.46. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. MDT's industry had an average PEG ratio of 2.07 as of yesterday's close.
The Medical - Products industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 144, positioning it in the bottom 42% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Medtronic (MDT) Stock Moves -1.61%: What You Should Know
Medtronic (MDT - Free Report) closed at $91.73 in the latest trading session, marking a -1.61% move from the prior day. Meanwhile, the Dow lost 0.16%, and the Nasdaq, a tech-heavy index, added 0.55%.
The medical device company's shares have seen a decrease of 2.11% over the last month, not keeping up with the Medical sector's gain of 7.99% and the S&P 500's gain of 3.83%.
The investment community will be closely monitoring the performance of Medtronic in its forthcoming earnings report. The company is scheduled to release its earnings on November 18, 2025. The company is predicted to post an EPS of $1.31, indicating a 3.97% growth compared to the equivalent quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $8.86 billion, up 5.44% from the year-ago period.
For the full year, the Zacks Consensus Estimates are projecting earnings of $5.62 per share and revenue of $35.83 billion, which would represent changes of +2.37% and +6.82%, respectively, from the prior year.
It is also important to note the recent changes to analyst estimates for Medtronic. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.01% lower. Medtronic presently features a Zacks Rank of #3 (Hold).
With respect to valuation, Medtronic is currently being traded at a Forward P/E ratio of 16.6. This valuation marks a discount compared to its industry average Forward P/E of 18.01.
Also, we should mention that MDT has a PEG ratio of 2.46. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. MDT's industry had an average PEG ratio of 2.07 as of yesterday's close.
The Medical - Products industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 144, positioning it in the bottom 42% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.